Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection

Infections with >1 Mycobacterium tuberculosis strain(s) are underrecognized. We show, in vitro and in vivo, how first-line treatment conferred a competitive growth advantage to amplify a multidrug-resistant M. tuberculosis strain in a patient with mixed infection. Diagnostic techniques that ident...

Full description

Bibliographic Details
Main Authors: Suzanne M. Hingley-Wilson, Rosalyn Casey, David Connell, Samuel Bremang, Jason T. Evans, Peter M. Hawkey, Grace E. Smith, Annette Jepson, Stuart Philip, Onn Min Kon, Ajit Lalvani
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2013-07-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/19/7/13-0313_article
_version_ 1819263111837777920
author Suzanne M. Hingley-Wilson
Rosalyn Casey
David Connell
Samuel Bremang
Jason T. Evans
Peter M. Hawkey
Grace E. Smith
Annette Jepson
Stuart Philip
Onn Min Kon
Ajit Lalvani
author_facet Suzanne M. Hingley-Wilson
Rosalyn Casey
David Connell
Samuel Bremang
Jason T. Evans
Peter M. Hawkey
Grace E. Smith
Annette Jepson
Stuart Philip
Onn Min Kon
Ajit Lalvani
author_sort Suzanne M. Hingley-Wilson
collection DOAJ
description Infections with >1 Mycobacterium tuberculosis strain(s) are underrecognized. We show, in vitro and in vivo, how first-line treatment conferred a competitive growth advantage to amplify a multidrug-resistant M. tuberculosis strain in a patient with mixed infection. Diagnostic techniques that identify mixed tubercle bacilli populations are needed to curb the spread of multidrug resistance.
first_indexed 2024-12-23T20:08:24Z
format Article
id doaj.art-5f72ad35721e4da483bbe6b8dc4c7ed4
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-12-23T20:08:24Z
publishDate 2013-07-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-5f72ad35721e4da483bbe6b8dc4c7ed42022-12-21T17:32:52ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592013-07-011971138114110.3201/eid1907.130313Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed InfectionSuzanne M. Hingley-WilsonRosalyn CaseyDavid ConnellSamuel BremangJason T. EvansPeter M. HawkeyGrace E. SmithAnnette JepsonStuart PhilipOnn Min KonAjit LalvaniInfections with >1 Mycobacterium tuberculosis strain(s) are underrecognized. We show, in vitro and in vivo, how first-line treatment conferred a competitive growth advantage to amplify a multidrug-resistant M. tuberculosis strain in a patient with mixed infection. Diagnostic techniques that identify mixed tubercle bacilli populations are needed to curb the spread of multidrug resistance.https://wwwnc.cdc.gov/eid/article/19/7/13-0313_articleMycobacterium tuberculosisco-infectiontreatment resistancemultidrug resistantdrug sensitivetuberculosis and other mycobacteria
spellingShingle Suzanne M. Hingley-Wilson
Rosalyn Casey
David Connell
Samuel Bremang
Jason T. Evans
Peter M. Hawkey
Grace E. Smith
Annette Jepson
Stuart Philip
Onn Min Kon
Ajit Lalvani
Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection
Emerging Infectious Diseases
Mycobacterium tuberculosis
co-infection
treatment resistance
multidrug resistant
drug sensitive
tuberculosis and other mycobacteria
title Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection
title_full Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection
title_fullStr Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection
title_full_unstemmed Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection
title_short Undetected Multidrug-Resistant Tuberculosis Amplified by First-line Therapy in Mixed Infection
title_sort undetected multidrug resistant tuberculosis amplified by first line therapy in mixed infection
topic Mycobacterium tuberculosis
co-infection
treatment resistance
multidrug resistant
drug sensitive
tuberculosis and other mycobacteria
url https://wwwnc.cdc.gov/eid/article/19/7/13-0313_article
work_keys_str_mv AT suzannemhingleywilson undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection
AT rosalyncasey undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection
AT davidconnell undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection
AT samuelbremang undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection
AT jasontevans undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection
AT petermhawkey undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection
AT graceesmith undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection
AT annettejepson undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection
AT stuartphilip undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection
AT onnminkon undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection
AT ajitlalvani undetectedmultidrugresistanttuberculosisamplifiedbyfirstlinetherapyinmixedinfection